$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000093454917000019 Filed on May 10, 2017

Income Statement

Concept	2017 Q1	2016 Q4	2016 Q1
Revenue	$8.854M	$21.97M	$24.72M
YoY Change	-64.18%	-41.41%	-27.74%
Cost Of Revenue	$670.0K	$3.310M	$1.570M
YoY Change	-57.32%	-57.35%	-83.17%
Gross Profit	$8.190M	$18.66M	$23.15M
YoY Change	-64.62%	-37.26%	-6.99%
Gross Profit Margin	92.5%	84.94%	93.65%
Selling, General & Admin	$7.540M	$13.29M	$12.10M
YoY Change	-37.69%	6.58%	-21.22%
% of Gross Profit	92.06%	71.22%	52.27%
Research & Development	$320.0K	$560.0K	$520.0K
YoY Change	-38.46%	-34.88%	-48.0%
% of Gross Profit	3.91%	3.0%	2.25%
Depreciation & Amortization	$5.540M	$6.300M	$10.80M
YoY Change	-48.72%	-52.27%	-17.54%
% of Gross Profit	67.64%	33.76%	46.67%
Operating Expenses	$13.37M	$20.07M	$25.13M
YoY Change	-46.8%	-24.8%	-15.7%
Operating Profit	-$11.58M	-$9.055M	-$9.702M
YoY Change	19.32%	-92.0%	-28.71%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$696.0K	$592.0K	-$3.000K
YoY Change	-23300.0%		-101.32%
Pretax Income	-$10.88M	-$8.463M	-$9.705M
YoY Change	12.11%	-92.52%	-27.48%
Income Tax	$1.241M	$2.414M	$192.0K
% Of Pretax Income
Net Earnings	-$11.83M	-$10.61M	-$9.965M
YoY Change	18.72%	-90.85%	-24.11%
Net Earnings / Revenue	-133.61%	-48.3%	-40.31%
Basic Earnings Per Share
Diluted Earnings Per Share	-$235.0K	-$211.2K	-$199.7K
COMMON SHARES
Basic Shares Outstanding	50.33M shares	50.46M shares	49.93M shares
Diluted Shares Outstanding	50.33M shares	50.24M shares	49.93M shares

Balance Sheet

Concept	2017 Q1	2016 Q4	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$145.2M	$147.0M	$145.3M
YoY Change	-0.07%	8.73%	-6.14%
Cash & Equivalents	$65.84M	$139.1M	$145.3M
Short-Term Investments	$90.90M	$19.40M
Other Short-Term Assets	$16.60M	$14.70M	$16.10M
YoY Change	3.11%	-2.65%	-5.29%
Inventory
Prepaid Expenses
Receivables	$7.781M	$26.75M	$25.18M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$169.7M	$188.5M	$186.6M
YoY Change	-9.06%	2.51%	-7.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$94.00K	$127.0K	$231.0K
YoY Change	-59.31%	-53.31%	-45.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.200M	$0.00
YoY Change
Other Assets	$336.0K	$618.0K	$1.111M
YoY Change	-69.76%	-44.32%	212.96%
Total Long-Term Assets	$103.2M	$107.5M	$153.2M
YoY Change	-32.66%	-34.45%	-49.86%
TOTAL ASSETS
Total Short-Term Assets	$169.7M	$188.5M	$186.6M
Total Long-Term Assets	$103.2M	$107.5M	$153.2M
Total Assets	$272.9M	$296.0M	$339.8M
YoY Change	-19.7%	-14.92%	-33.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.70M	$14.30M	$14.60M
YoY Change	-19.86%	-17.34%	14.96%
Accrued Expenses		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.79M	$28.19M	$33.20M
YoY Change	-55.45%	-15.15%	1.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$380.0K	$369.0K	$345.0K
YoY Change	10.14%	18.65%	38.0%
Total Long-Term Liabilities	$380.0K	$369.0K	$345.0K
YoY Change	10.14%	18.65%	38.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.79M	$28.19M	$33.20M
Total Long-Term Liabilities	$380.0K	$369.0K	$345.0K
Total Liabilities	$15.17M	$28.56M	$33.75M
YoY Change	-55.06%	-15.37%	-1.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$354.0M	-$342.2M	-$298.1M
YoY Change	18.76%	18.76%	111.08%
Common Stock	$51.00K	$50.00K	$50.00K
YoY Change	2.0%	-1.96%	-1.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$34.64M	$34.64M	$34.64M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	1.729M shares	1.729M shares	1.729M shares
Shareholders Equity	$256.1M	$265.6M	$302.0M
YoY Change
Total Liabilities & Shareholders Equity	$272.9M	$296.0M	$339.8M
YoY Change	-19.7%	-14.92%	-33.02%

Cashflow Statement

Concept	2017 Q1	2016 Q4	2016 Q1
OPERATING ACTIVITIES
Net Income	-$11.83M	-$10.61M	-$9.965M
YoY Change	18.72%	-90.85%	-24.11%
Depreciation, Depletion And Amortization	$5.540M	$6.300M	$10.80M
YoY Change	-48.72%	-52.27%	-17.54%
Cash From Operating Activities	-$976.0K	$10.90M	$11.11M
YoY Change	-108.78%	-190.08%	-170.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$200.0K	$4.000K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$72.50M	$900.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$72.47M	$700.0K	-$1.004M
YoY Change	7118.13%		-91.38%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net	$25.00K		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$230.0K	0.000	$0.00
YoY Change		-100.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-$976.0K	10.90M	$11.11M
Cash From Investing Activities	-$72.47M	700.0K	-$1.004M
Cash From Financing Activities	$230.0K	0.000	$0.00
Net Change In Cash	-$73.22M	11.60M	$10.11M
YoY Change	-824.48%	-151.56%	-130.7%
FREE CASH FLOW
Cash From Operating Activities	-$976.0K	$10.90M	$11.11M
Capital Expenditures	$0.00	-$200.0K	$4.000K
Free Cash Flow	-$976.0K	$11.10M	$11.11M
YoY Change	-108.79%	-191.74%	-170.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	3740000	USD
CY2017Q1	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-10830000	USD
CY2016Q3	actg	A1st Loan Warrant Condition Proceedsfrom Private Financing A1stLoanWarrantConditionProceedsfromPrivateFinancing	10000000	USD
CY2017Q1	actg	Bridge Installment Shares BridgeInstallmentShares	37500	shares
CY2017Q1	actg	Bridge Installment Shares BridgeInstallmentShares	150000	shares
CY2017Q1	actg	Bridge Loan Conversion Price BridgeLoanConversionPrice	8.1653
CY2017Q1	actg	Bridge Warrant Share BridgeWarrantShare	50000	shares
CY2017Q1	actg	Bridge Warrant Share BridgeWarrantShare	200000	shares
CY2017Q1	actg	Bridgeloanconversionlimit Bridgeloanconversionlimit	981958	shares
CY2017Q1	actg	Bridgeloanstatedinterestrate Bridgeloanstatedinterestrate	0.08
CY2016Q1	actg	Contingent Legal Fees ContingentLegalFees	4109000	USD
CY2017Q1	actg	Contingent Legal Fees ContingentLegalFees	627000	USD
CY2017Q1	actg	Fair Valueof Profits Interest FairValueofProfitsInterest	550000	USD
CY2016Q4	actg	Investmentwarrants Investmentwarrants	1960000	USD
CY2017Q1	actg	Investmentwarrants Investmentwarrants	2196000	USD
CY2016Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	7723000	USD
CY2017Q1	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	6386000	USD
CY2014	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	3	patents
CY2015	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	6	patents
CY2016	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	2	patents
CY2017Q1	actg	Numberofpatentportfoliosacquired Numberofpatentportfoliosacquired	1	patents
CY2016Q4	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	358043000	USD
CY2017Q1	actg	Patents Accumulated Amortization PatentsAccumulatedAmortization	363558000	USD
CY2016Q4	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	86319000	USD
CY2017Q1	actg	Patents Net Of Accumulated Amortization PatentsNetOfAccumulatedAmortization	80804000	USD
CY2016Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	522000	USD
CY2017Q1	actg	Research Consulting And Other Expenses Business Development ResearchConsultingAndOtherExpensesBusinessDevelopment	320000	USD
CY2016Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	13908000	USD
CY2017Q1	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	3078000	USD
CY2017Q1	actg	Secured Convertible Promissory Note SecuredConvertiblePromissoryNote	21000000	USD
CY2016Q3	actg	Secured Convertible Promissory Note SecuredConvertiblePromissoryNote	20000000	USD
CY2016	actg	Total Investment Long Term TotalInvestmentLongTerm	20576000	USD
CY2017Q1	actg	Total Investment Long Term TotalInvestmentLongTerm	21945000	USD
CY2016Q4	actg	Unamortizedloandiscount Unamortizedloandiscount	-1384000	USD
CY2017Q1	actg	Unamortizedloandiscount Unamortizedloandiscount	-1251000	USD
CY2017Q1	actg	Unrecognized Expensefor Profits Interests UnrecognizedExpenseforProfitsInterests	537000	USD
CY2017Q1	actg	Upfront Shares UpfrontShares	25000	shares
CY2017Q1	actg	Upfront Shares UpfrontShares	100000	shares
CY2017Q1	actg	Veritone Bridge Loan Advance1 VeritoneBridgeLoanAdvance1	1000000	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50587722	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	ACACIA RESEARCH CORP
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	14283000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11712000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26750000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7781000	USD
CY2016	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	576000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	369000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-76000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-49000	USD
CY2017Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	642453000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	644794000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10760000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5515000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2350445	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4420717	shares
CY2016Q4	us-gaap	Assets Assets	296003000	USD
CY2017Q1	us-gaap	Assets Assets	272861000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	188490000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	169682000	USD
CY2017Q1	us-gaap	Bridge Loan BridgeLoan	4000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135223000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145329000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127540000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54321000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	10106000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-73219000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50476042	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50533407	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50476042	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50533407	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	50000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	51000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9898000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11803000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9830000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12094000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10803000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5540000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2016Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2017Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.11
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	11451000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16819000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5421000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6707000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	19150000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	21256000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	80804000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7994000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6916000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9705000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10880000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	192000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1241000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2733000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2576000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8325000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18969000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	134000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1738000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	798000	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	3000	USD
CY2017Q1	us-gaap	Interest Income Other InterestIncomeOther	668000	USD
CY2016Q4	us-gaap	Interest Receivable InterestReceivable	286000	USD
CY2017Q1	us-gaap	Interest Receivable InterestReceivable	585000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	28560000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	15170000	USD
CY2016Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25000	USD
CY2016Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	0	USD
CY2017Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	174152000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	296003000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	272861000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	28191000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	14790000	USD
CY2016Q1	us-gaap	Licenses Revenue LicensesRevenue	24721000	USD
CY2017Q1	us-gaap	Licenses Revenue LicensesRevenue	8854000	USD
CY2016	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0115
CY2016Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	18616000	USD
CY2017Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	19749000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	1854000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	1563000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	230000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1004000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72470000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11110000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-979000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-9965000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-11830000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	68000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-291000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9965000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11830000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	696000	USD
CY2016Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	34423000	USD
CY2017Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	20430000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9702000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11576000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	491000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	336000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	67000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	13000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1742000	USD
CY2017Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	0	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	369000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	380000	USD
CY2016Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	69000	USD
CY2017Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-348000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2016Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2017Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3245000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5138000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	102682000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	255000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-9897000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-12121000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11512000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11515000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-342198000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-354028000	USD
CY2016Q1	us-gaap	Royalty Expense RoyaltyExpense	1573000	USD
CY2017Q1	us-gaap	Royalty Expense RoyaltyExpense	666000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1735000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2128000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	19443000	USD
CY2017Q1	us-gaap	Short Term Investments ShortTermInvestments	90927000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	265589000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	256128000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	267443000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	257691000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1729408	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	34640000	USD
CY2016Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49925550	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50333056	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49925550	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50333056	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	49925550	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	50333056	shares
CY2017Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations. </font><font style="font-family:inherit;font-size:10pt;">Two</font><font style="font-family:inherit;font-size:10pt;"> licensees individually accounted for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">73%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and four licensees accounted for </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> of revenues recognized during the three months ended March 31, 2016. For the three months ended </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and 2016, </font><font style="font-family:inherit;font-size:10pt;">92%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions, based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable revenue arrangement. The Company does not have any material foreign operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Two licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">84%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Four licensees individually represented approximately </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">39%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">16%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> of accounts receivable at December 31, 2016. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.  </font><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, stock-based compensation expense, impairment of marketable securities and patent-related intangible assets, the determination of the economic useful life of amortizable intangible assets, income taxes and valuation allowances against net deferred tax assets, the valuation of the loan and equity instruments discussed at Note 5 and the application of the acquisition method of accounting for business combinations, require its most difficult, subjective or complex judgments.</font></div></div>

Files In Submission

Name	View Source	Status
0000934549-17-000019-index-headers.html	Edgar Link	pending
0000934549-17-000019-index.html	Edgar Link	pending
0000934549-17-000019.txt	Edgar Link	pending
0000934549-17-000019-xbrl.zip	Edgar Link	pending
actg-20170331.xml	Edgar Link	completed
actg-20170331.xsd	Edgar Link	pending
actg-20170331_cal.xml	Edgar Link	unprocessable
actg-20170331_def.xml	Edgar Link	unprocessable
actg-20170331_lab.xml	Edgar Link	unprocessable
actg-20170331_pre.xml	Edgar Link	unprocessable
actg10q03312017.htm	Edgar Link	pending
ex10103312017.htm	Edgar Link	pending
ex31103312017.htm	Edgar Link	pending
ex31203312017.htm	Edgar Link	pending
ex32103312017.htm	Edgar Link	pending
ex32203312017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graphicactga02a06.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2017 Q1 Form 10-Q Financial Statement

#000093454917000019 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2017 Q1 Form 10-Q Financial Statement

#000093454917000019 Filed on May 10, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg